<DOC>
	<DOC>NCT00285623</DOC>
	<brief_summary>The purpose of this study is to collect information, after exposure to TachoSil ®, of all thromboembolic events, immunological events and drug interactions leading to thromboembolic events or major bleeding. In addition, pharmacoeconomic data will be collected.</brief_summary>
	<brief_title>Observational Cohort Study of TachoSil (TC-018-IN)</brief_title>
	<detailed_description />
	<mesh_term>Blood Loss, Surgical</mesh_term>
	<mesh_term>Thrombin</mesh_term>
	<criteria>All subjects, treated with TachoSil ® by the participating physicians, will be registered with a set of basic data from their already existing data (i.e. no additional diagnostic procedures will be performed). Subjects who will provide their written informed consent to use existing data, allow direct access to data and data processing.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>Collection of all thromboembolic events,</keyword>
	<keyword>immunological events and drug interactions leading to thromboembolic events or major</keyword>
	<keyword>bleeding after exposure to TachoSil®.</keyword>
</DOC>